+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colorectal Cancer"

Oncology Market Forecast (2020-2025) - Product Thumbnail Image

Oncology Market Forecast (2020-2025)

  • Report
  • August 2020
  • 142 Pages
  • Global
From
From
From
From
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
Oncology. Edition No. 1. Mount Sinai Expert Guides - Product Thumbnail Image

Oncology. Edition No. 1. Mount Sinai Expert Guides

  • Book
  • October 2019
  • 632 Pages
Oncology. Edition No. 3. Lecture Notes - Product Thumbnail Image

Oncology. Edition No. 3. Lecture Notes

  • Book
  • January 2016
  • 368 Pages
Loading Indicator

Colorectal cancer is a type of cancer that affects the colon and rectum. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. Treatment for colorectal cancer typically involves surgery, chemotherapy, and radiation therapy. In recent years, targeted therapies and immunotherapies have been developed to treat colorectal cancer. The oncology market for colorectal cancer is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as Merck, Bristol-Myers Squibb, and Roche, as well as biotechnology companies such as ImmunoGen, Exelixis, and Incyte. Additionally, medical device companies such as Medtronic and Boston Scientific are involved in the development of treatments for colorectal cancer. Show Less Read more